dr. debu tripathy discusses the updated emilia trial results for t-dm1
Published 11 years ago • 153 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:07
dr. tripathy discusses impact of t-dm1 in her2 breast cancer
-
1:25
dr. debu tripathy reviews the phase iii confirm trial
-
1:04
dr. kimberly blackwell discusses the t-dm1 emilia trial coprimary endpoints
-
1:22
dr. debu tripathy gives an overview of targeted therapies for breast cancer
-
1:38
t-dm1 plus pertuzumab in the marianne trial
-
1:20:55
treatment of metastatic breast cancer
-
33:35
which metastatic breast cancer treatment is right for you? what you need to know
-
7:39
breast cancer stage 4 new treatments 2019 - dm (aiims) - targeted therapy, immunotherapy
-
1:52
dr. mark pegram discusses earlier treatment with t-dm1
-
0:37
debu tripathy, md discusses the paloma-2 trial outcomes in er /her2- advanced breast cancer
-
1:20
dr. tripathy on decision-making for sequencing therapies for her2-positive mbc
-
0:54
dr. tripathy on the treatment of patients with metastatic breast cancer
-
1:08
dr. tripathy on standard and emerging treatment advances for her2 breast cancer
-
1:09
dr. tripathy on trastuzumab deruxtecan versus t-dm1 in her2-expressing breast cancers
-
2:55
debu tripathy, md, introduces new information oncdk4/6 inhibitors discussed at asco20
-
1:10
dr. tripathy on targeting her2 in breast cancer
-
1:19
debu tripathy on hormonal therapy for breast cancer
-
4:17
debu tripathy, md, discusses recent fda approvals and her2 metastatic breast cancer management
-
1:50
dr. tripathy on the management of hr early-stage breast cancer
-
3:27
dr. tripathy on neoadjuvant treatment strategies in her2 breast cancer
-
1:51
dr. tripathy discusses lurbinectedin in breast cancer
-
2:13
dr. tripathy on frontline endocrine therapies in hr breast cancer